These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26526830)

  • 1. UGT1A1 Mediated Drug Interactions and its Clinical Relevance.
    Goon CP; Wang LZ; Wong FC; Thuya WL; Ho PC; Goh BC
    Curr Drug Metab; 2016; 17(2):100-6. PubMed ID: 26526830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review.
    Stingl JC; Bartels H; Viviani R; Lehmann ML; Brockmöller J
    Pharmacol Ther; 2014 Jan; 141(1):92-116. PubMed ID: 24076267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the UDP glucuronosyltransferase activity of human liver microsomes genotyped for the UGT1A1*28 polymorphism.
    Zhang D; Zhang D; Cui D; Gambardella J; Ma L; Barros A; Wang L; Fu Y; Rahematpura S; Nielsen J; Donegan M; Zhang H; Humphreys WG
    Drug Metab Dispos; 2007 Dec; 35(12):2270-80. PubMed ID: 17898154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the in vitro/in vivo potential of five berries (bilberry, blueberry, cranberry, elderberry, and raspberry ketones) commonly used as herbal supplements to inhibit uridine diphospho-glucuronosyltransferase.
    Choi EJ; Park JB; Yoon KD; Bae SK
    Food Chem Toxicol; 2014 Oct; 72():13-9. PubMed ID: 24997313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances in research on regulatory effects of chemical ingredients of traditional Chinese medicine on UDP-glucuronosyltransferase 1A1 expression and activity].
    Xin H; Xu W
    Zhongguo Zhong Yao Za Zhi; 2017 Feb; 42(3):428-432. PubMed ID: 28952244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphism.
    Font A; Sánchez JM; Tarón M; Martinez-Balibrea E; Sánchez JJ; Manzano JL; Margelí M; Richardet M; Barnadas A; Abad A; Rosell R
    Invest New Drugs; 2003 Nov; 21(4):435-43. PubMed ID: 14586211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased frequency of uridine diphosphate glucuronosyltransferase 1A1 7/7 in patients experiencing severe irinotecan-induced toxicities.
    Fakih MG; Ross ME; Starostik P
    Clin Colorectal Cancer; 2007 Jul; 6(8):583-7. PubMed ID: 17681105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between TA-repeat polymorphism in the promoter region of UGT1A1 and breast cancer risk: a meta-analysis.
    Yao L; Qiu LX; Yu L; Yang Z; Yu XJ; Zhong Y; Yu L
    Breast Cancer Res Treat; 2010 Aug; 122(3):879-82. PubMed ID: 20087647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective analysis of UGT1A1 promoter polymorphism for irinotecan dose escalation in metastatic colorectal cancer patients treated with bevacizumab plus FOLFIRI as the first-line setting: study protocol for a randomized controlled trial.
    Yeh YS; Tsai HL; Huang CW; Wang JH; Lin YW; Tang HC; Sung YC; Wu CC; Lu CY; Wang JY
    Trials; 2016 Jan; 17():46. PubMed ID: 26811156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of in vitro inhibitors against UDP-glucuronosyltransferase 1A1 in uva-ursi extracts and evaluation of in vivo uva-ursi-drug interactions.
    Park JB; Kim D; Min JS; Jeong S; Cho DY; Zheng YF; Yoon KD; Bae SK
    Food Chem Toxicol; 2018 Oct; 120():651-661. PubMed ID: 30075316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of UGT1A1*28 and UGT1A1*6 for irinotecan-induced adverse drug reaction].
    Onoue M; Inui K
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1080-5. PubMed ID: 18633245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics and irinotecan therapy.
    Hahn KK; Wolff JJ; Kolesar JM
    Am J Health Syst Pharm; 2006 Nov; 63(22):2211-7. PubMed ID: 17090741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UDP-glucuronosyltransferases and clinical drug-drug interactions.
    Kiang TK; Ensom MH; Chang TK
    Pharmacol Ther; 2005 Apr; 106(1):97-132. PubMed ID: 15781124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of UDP-glucuronosyltransferase and drug metabolism.
    Maruo Y; Iwai M; Mori A; Sato H; Takeuchi Y
    Curr Drug Metab; 2005 Apr; 6(2):91-9. PubMed ID: 15853761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
    Bosch TM; Meijerman I; Beijnen JH; Schellens JH
    Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the UGT1A1*28 allele on unconjugated hyperbilirubinemia in HIV-positive patients receiving Atazanavir: a systematic review.
    Culley CL; Kiang TK; Gilchrist SE; Ensom MH
    Ann Pharmacother; 2013 Apr; 47(4):561-72. PubMed ID: 23548653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [UGT1A1 Genotyping for Proper Use of Irinotecan].
    Matsuoka A; Ando Y
    Rinsho Byori; 2015 Jul; 63(7):876-82. PubMed ID: 26591441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for puerarin metabolism in human liver microsomes.
    Luo CF; Cai B; Hou N; Yuan M; Liu SM; Ji H; Xiong LG; Xiong W; Luo JD; Chen MS
    Arch Toxicol; 2012 Nov; 86(11):1681-90. PubMed ID: 22648071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Practical and High-Affinity Fluorescent Probe for Uridine Diphosphate Glucuronosyltransferase 1A1: A Good Surrogate for Bilirubin.
    Lv X; Feng L; Ai CZ; Hou J; Wang P; Zou LW; Cheng J; Ge GB; Cui JN; Yang L
    J Med Chem; 2017 Dec; 60(23):9664-9675. PubMed ID: 29125289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of metabolism-mediated herb-drug interactions.
    Na DH; Ji HY; Park EJ; Kim MS; Liu KH; Lee HS
    Arch Pharm Res; 2011 Nov; 34(11):1829-42. PubMed ID: 22139684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.